The Scientist's New LabConsumer Section Reduces Legwork For Potential Buyers

Yogi Berra, the affable former manager for the New York Yankees, was once quoted as saying, "A nickel ain't worth a dime anymore." In spite of his confusion about the value of money, Berra's statement addresses the financial concerns of most professionals, be they athletes or scientists. Small products like pipette tips, large ones like automated DNA sequencers, and a wide range of equipment in between constitute the tools of the scientific trade. The cost and quality of these products directl

Written byScott Shoemaker
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Yogi Berra, the affable former manager for the New York Yankees, was once quoted as saying, "A nickel ain't worth a dime anymore." In spite of his confusion about the value of money, Berra's statement addresses the financial concerns of most professionals, be they athletes or scientists.

Small products like pipette tips, large ones like automated DNA sequencers, and a wide range of equipment in between constitute the tools of the scientific trade. The cost and quality of these products directly affect a scientist's output. Many have experienced the frustration of substituting a cheaper product in an established protocol only to end up losing valuable samples or time and to be left wondering, "What the heck went wrong with the results?" Then there are those who purchase only top-of-the line lab equipment. However, buying the most expensive laboratory products doesn't always ensure success and can quickly shorten the economic life ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies